Learning from patient involvement in a clinical study analyzing PET/CT in women with advanced breast cancer

by Marianne Vogsen, Susanne Geneser, Marie Lykke Rasmussen, Mogens Hørder, Malene Grubbe Hildebrandt
Published 2020-01-01

Higher Interrater Agreement of FDG-PET/CT than Bone Scintigraphy in Diagnosing Bone Recurrent Breast Cancer

by Jorun Holm, Ziba Ahangarani Farahani, Oke Gerke, Christina Baun, Kirsten Falch, Malene Grubbe Hildebrandt
Published 2020-11-01

Group-sequential analysis may allow for early trial termination: illustration by an intra-observer repeatability study

by Oke Gerke, Mie H. Vilstrup, Ulrich Halekoh, Malene Grubbe Hildebrandt, Poul Flemming Høilund-Carlsen
Published 2017-09-01

Prognostic Value of Dual-Time-Point ¹⁸F-Fluorodeoxyglucose PET/CT in Metastatic Breast Cancer: An Exploratory Study of Quantitative Measures

by Mohammad Naghavi-Behzad, Charlotte Bjerg Petersen, Marianne Vogsen, Poul-Erik Braad, Malene Grubbe Hildebrandt, Oke Gerke
Published 2020-06-01

Prevalence of focal incidental breast uptake on FDG-PET/CT and risk of malignancy: a systematic review and meta-analysis

by Else Marie Aarstad, Petter Nordhaug, Mohammad Naghavi-Behzad, Lisbet Brønsro Larsen, Oke Gerke, Malene Grubbe Hildebrandt
Published 2019-09-01

FDG-PET/CT Versus Contrast-Enhanced CT for Response Evaluation in Metastatic Breast Cancer: A Systematic Review

by Fredrik Helland, Martine Hallin Henriksen, Oke Gerke, Marianne Vogsen, Poul Flemming Høilund-Carlsen, Malene Grubbe Hildebrandt
Published 2019-08-01

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST

by Marianne Vogsen, Jakob Lykke Bülow, Lasse Ljungstrøm, Hjalte Rasmus Oltmann, Tural Asgharzadeh Alamdari, Mohammad Naghavi-Behzad, Poul-Erik Braad, Oke Gerke, Malene Grubbe Hildebrandt
Published 2021-04-01

Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer

by Mohammad Naghavi-Behzad, Hjalte Rasmus Oltmann, Tural Asgharzadeh Alamdari, Jakob Lykke Bülow, Lasse Ljungstrøm, Poul-Erik Braad, Jon Thor Asmussen, Marianne Vogsen, Annette Raskov Kodahl, Oke Gerke, Malene Grubbe Hildebrandt
Published 2021-08-01

Benefits and harms of implementing [18F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study

by Marianne Vogsen, Jeanette Dupont Jensen, Oke Gerke, Anne Marie Bak Jylling, Jon Thor Asmussen, Ivar Yannick Christensen, Poul-Erik Braad, Peter Thye-Rønn, Katrine Lydolph Søe, Marianne Ewertz, Malene Grubbe Hildebrandt
Published 2021-09-01

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond

by Malene Grubbe Hildebrandt, Jeppe Faurholdt Lauridsen, Marianne Vogsen, Jorun Holm, Mie Holm Vilstrup, Poul-Erik Braad, Oke Gerke, Mads Thomassen, Marianne Ewertz, Poul Flemming Høilund-Carlsen, The Centre for Personalized Response Monitoring in Oncology (PREMIO)
Published 2019-08-01